S
The prevalence of cerebral palsy (CP) in children born at 20 to 27 weeks of age and weighing 500 to 1,249 g has steadily declined in the last 10 or so years, reversing a trend of growing prevalence leading up to 1992–1994 (the peak period for CP), according to a Canadian study.
The analysis, involving 2,318 infants born very prematurely between 1974 and 2003, is important because a decrease in prevalence suggests successful prevention of CP through improved perinatal care.
Experts are unsure as to the cause of the decrease. Available evidence fails to support the belief that the drop resulted from the use of antenatal steroids, magnesium sulfate, thyroid hormone, surfactant, vitamin K, or phenobarbital. However, it may be the result of a number of changes in care, such as less use of postnatal corticosteroids.
Robertson CM, Watt MJ, Yasui Y. Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years. JAMA. 2007;297:2733-2740.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More